ENTITY

Abiomed Inc (ABMD US)

16
Analysis
Health Care • United States
ABIOMED, Inc. develops, manufactures and markets cardiovascular products.The Company develops technologies designed to assist or replace the pumping function of the heart. Abiomed's products and services are used by healthcare professionals in the U.S., Canada and the EU.
more
bearish•S&P 500 INDEX
•20 May 2020 07:34

U.S. Equity Strategy: Round Trip Back To Resistance

Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...

Logo
430 Views
Share
bullish•S&P 500 INDEX
•08 Jun 2018 03:58

U.S. Equity Strategy: Opportunities in Refiners & Med Device Makers

U.S. equity markets remain resilient. Led by strength in technology and biotech, the Nasdaq hit a new all-time high yesterday. Small-cap indexes...

Logo
249 Views
Share
bullish•MSCI ACWI Index
•11 May 2018 02:11

Global Strategy: Opportunities Within Mobile Payments, Metals & Mining, and Utilities

We believe the secular mobile payments theme has room to run, and we expect related stocks to continue outperforming... see pages 2-4 for...

Logo
531 Views
Share
bullish•S&P 500 INDEX
•24 Apr 2018 23:07

U.S. Equity Strategy: Opportunities in Energy & Health Care Stocks

While defensive sectors continue to lag, one cyclical sector, Energy, has surged to the top of our relative strength rankings. Though we continue...

Logo
315 Views
Share
bullish•S&P 500 INDEX
•20 Sep 2017 22:37

Vermilion Macro Vision - U.S. Equity Strategy: Sector Commentaries with Recommendations

Our last strategy “Fake Moves” highlighted our view that the markets were showing no parallel to the “fake news” narrative and indeed provided a...

Logo
555 Views
Share
x